Journal article
Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial
Abstract
BACKGROUND: Diabetes and cardiovascular disease increase the risk of incident cognitive dysfunction. Identification of novel biochemical markers for cognitive dysfunction may identify people at the highest risk while yielding insights regarding the pathophysiology of cognitive dysfunction.
OBJECTIVE: To identify cardiovascular biomarkers in serum that are independent predictors of cognitive dysfunction in individuals with dysglycemia.
Authors
Cukierman-Yaffe T; Lee S-F; Pare G; McQueen M; Hess S; Gerstein HC
Journal
Journal of Alzheimer’s Disease, Vol. 87, No. 3, pp. 1143–1150
Publisher
SAGE Publications
Publication Date
2022
DOI
10.3233/jad-215195
ISSN
1387-2877